Cearley Cassia's most recent trade in Icosavax Inc was a trade of 7,934 Common Stock done at an average price of $15.5 . Disclosure was reported to the exchange on Dec. 20, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Icosavax Inc | Cassia Cearley | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 15.46 per share. | 20 Dec 2023 | 7,934 | 130,694 | - | 15.5 | 122,637 | Common Stock |
Icosavax Inc | Cearley Cassia | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 16.01 per share. | 13 Dec 2023 | 8,759 | 131,200 | - | 16.0 | 140,190 | Common Stock |
Icosavax Inc | Cassia Cearley | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 8.86 per share. | 31 Jul 2023 | 1,888 | 139,959 | - | 8.9 | 16,731 | Common Stock |
Icosavax Inc | Cassia Cearley | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 23 May 2023 | 10,000 | 141,847 | - | 10 | 100,000 | Common Stock |
Icosavax Inc | Cassia Cearley | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 7.75 per share. | 06 Mar 2023 | 5,000 | 151,847 | - | 7.7 | 38,737 | Common Stock |
Icosavax Inc | Cassia Cearley | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 140,000 | 140,000 | - | - | Stock Option (Right to Buy) | |
Icosavax Inc | Cassia Cearley | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 10.69 per share. | 13 Feb 2023 | 1,660 | 156,847 | - | 10.7 | 17,750 | Common Stock |
Icosavax Inc | Cassia Cearley | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2023 | 25,102 | 2,511 | - | - | Stock Option (Right to Buy) | |
Icosavax Inc | Cassia Cearley | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. | 30 Jan 2023 | 25,102 | 156,840 | - | 0.8 | 21,086 | Common Stock |
Icosavax Inc | Cassia Cearley | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Icosavax Inc | Cassia Cearley | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 6.64 per share. | 29 Jul 2022 | 1,118 | 132,041 | - | 6.6 | 7,421 | Common Stock |
Icosavax Inc | Cassia Cearley | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 7.11 per share. | 29 Jul 2022 | 391 | 133,159 | - | 7.1 | 2,779 | Common Stock |
Icosavax Inc | Cassia Cearley | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 6.70 per share. | 29 Jul 2022 | 303 | 131,738 | - | 6.7 | 2,031 | Common Stock |
Icosavax Inc | Cassia Cearley | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 5.77 per share. | 31 May 2022 | 1,667 | 158,507 | - | 5.8 | 9,619 | Common Stock |
Icosavax Inc | Cassia Cearley | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. | 18 Mar 2022 | 35,137 | 133,550 | - | 0.8 | 29,515 | Common Stock |
Icosavax Inc | Cassia Cearley | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2022 | 35,137 | 27,613 | - | - | Stock Option (Right to Buy) | |
Icosavax Inc | Cassia Cearley | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 17.13 per share. | 07 Mar 2022 | 9,516 | 98,897 | - | 17.1 | 163,009 | Common Stock |
Icosavax Inc | Cassia Cearley | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 17.81 per share. | 07 Mar 2022 | 484 | 98,413 | - | 17.8 | 8,620 | Common Stock |
Icosavax Inc | Cassia Cearley | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 89,400 | 89,400 | - | - | Stock Option (Right to Buy) | |
Icosavax Inc | Cassia Cearley | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 21,256 | 108,413 | - | 0 | Common Stock | |
Icosavax Inc | Cassia Cearley | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2021 | 22,598 | 62,750 | - | - | Stock Option (Right to Buy) | |
Icosavax Inc | Cassia Cearley | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.83 per share. | 15 Nov 2021 | 22,598 | 85,491 | - | 0.8 | 18,756 | Common Stock |
Icosavax Inc | Cassia Cearley | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 15.00 per share. | 30 Jul 2021 | 27,750 | 62,893 | - | 15 | 416,250 | Common Stock |